Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Monoclonal antibodies
Apr 09, 2018
Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis
Apr 06, 2018
Asia-Pacific Rheumatoid Arthritis (RA) Therapeutics Markets to 2023 - Growth is Expected to Continue at a Moderate Pace from $5.6 Bn in 2016 to $9.5 Bn in 2023
Apr 06, 2018
Rheumatoid Arthritis Pricing, Reimbursement & Market Access 2018 - Visiongain Report
Apr 05, 2018
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis
Apr 03, 2018
EMA to Review Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Apr 02, 2018
MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones
Mar 28, 2018
Trianni, Inc. and NovaRock Biotherapeutics, Ltd. Announce Licensing Agreement
Mar 27, 2018
Uptake of Merck KGaA's Mavenclad in the European Multiple Sclerosis Market Currently Stalled Due to Restrictive Guidelines and Pending Additional Country-Level Approvals
Mar 26, 2018
Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Mar 26, 2018
Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference
Mar 23, 2018
Gastroenterologists Are Gearing Up to Incorporate Novel Oral Agents, Such As Pfizer's Xeljanz, into the Treatment Paradigm for Ulcerative Colitis, According to Latest Data from Spherix Global Insights
Mar 22, 2018
CIMZIA® (certolizumab pegol) label update marks major advance for women of childbearing age with chronic inflammatory disease in the U.S.
Mar 21, 2018
Sun Pharma Announces U.S. FDA Approval of ILUMYA(TM) (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
Mar 21, 2018
Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018
Mar 21, 2018
Neurodegenerative Diseases Drugs Market, 2023
Mar 21, 2018
Regeneron Genetics Center® Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection from Chronic Liver Disease
Mar 21, 2018
Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH)
Mar 19, 2018
EYLEA® (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Mar 16, 2018
Tumor Necrosis Factor Inhibitors Drug Market, 2024 - Humira and Remicade Have Made it to the List of Blockbuster Drugs of 2017 with Global Sales of US$ 17.6 Billion
Mar 14, 2018
ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results
‹‹
Page 35
››
Latest News
Apr 25, 2024
Universal Robots announces seamless integration with Siemens PLCs
Apr 25, 2024
Stak Mobility to Launch Second Mobility Hub in Pittsburgh; Sees Continued Momentum Across the US
Apr 25, 2024
DIC Algae Oil Sulfurized Extreme Pressure Additives Present Promising Alternatives to Lard Oils and Vegetable...
Apr 25, 2024
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment...
Apr 25, 2024
Ranpak to Hold Conference Call to Discuss First Quarter 2024 Results
Apr 25, 2024
Nodal Exchange Announces Cooperation with Deutsche Börse Market Data + Services
Apr 25, 2024
Corporate Funding for Energy Storage Sector Totaled $11.7 Billion in Q1 2024
Apr 25, 2024
Empowering Innovation: StatLab Welcomes Scientific Device Laboratory Into Family
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events